Medicare Enrolled
Dr. Sandra Schnall, M.D.
Hematology & Oncology · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schnall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schnall?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schnall
Dr. Sandra Schnall is a hematology & oncology specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schnall performed 163,619 Medicare services across 1,875 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schnall received a total of $8,643 from 68 pharmaceutical and/or device companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schnall is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in PA
$8,643 industry payments
Medicare Practice Summary
Medicare Utilization ↗163,619
Medicare services
Top 1% in PA for hematology & oncology
1,875
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,181 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
79,200 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
53,200 | $2 | $10 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,250 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 5,580 | $18 | $40 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,310 | $22 | $80 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,850 | $0 | $3 |
| Injection, fulvestrant, 25 mg | 2,042 | $8 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,546 | $100 | $220 |
| Anti-nausea injection (Aloxi/palonosetron) | 960 | $2 | $50 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
866 | $13 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
531 | $11 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
394 | $5 | $5 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
310 | $1 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
221 | $108 | $322 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
204 | $1 | $13 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
186 | $27 | $70 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
177 | $70 | $70 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
154 | $24 | $71 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
146 | $50 | $170 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
129 | $1 | $9 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
87 | $23 | $75 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
68 | $54 | $160 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
51 | $77 | $173 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
50 | $98 | $288 |
| New patient office visit, complex (60-74 min) | 30 | $175 | $300 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
21 | $19 | $75 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
17 | $2 | $30 |
| Biopsy of bone marrow | 15 | $136 | $385 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $142 | $311 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $75 | $145 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
48.7% high complexity
49.7% medium
1.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,643
Total received (2018-2024)
Avg $1,235/year across 7 years
Top 24% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
467
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,296 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$347 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$116
2023
$2,050
2022
$1,071
2021
$1,259
2020
$1,150
2019
$1,541
2018
$1,456
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$45
Exelixis Inc.
$37
Astellas Pharma US Inc
$18
Regeneron Healthcare Solutions, Inc.
$16
Top 3 companies account for 86.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$789
AstraZeneca Pharmaceuticals LP
$572
Janssen Pharmaceuticals, Inc
$511
Pharmacyclics LLC, An AbbVie Company
$447
Janssen Biotech, Inc.
$430
Amgen Inc.
$393
Novartis Pharmaceuticals Corporation
$377
Astellas Pharma US Inc
$357
Lilly USA, LLC
$335
Celgene Corporation
$314
PFIZER INC.
$251
Daiichi Sankyo Inc.
$232
Exelixis Inc.
$190
Seattle Genetics, Inc.
$188
Eisai Inc.
$182
Taiho Oncology, Inc.
$168
Incyte Corporation
$166
Servier Pharmaceuticals LLC
$159
Seagen Inc.
$155
BeiGene USA, Inc.
$120
Merck Sharp & Dohme Corporation
$114
EMD Serono, Inc.
$111
Foundation Medicine, Inc.
$106
Puma Biotechnology, Inc.
$100
ARRAY BIOPHARMA INC
$98
GENZYME CORPORATION
$92
ABBVIE INC.
$89
Ipsen Biopharmaceuticals, Inc
$86
EISAI INC.
$82
Pharmacosmos Therapeutics Inc.
$81
Stemline Therapeutics Inc.
$79
Pharmacyclics LLC, an AbbVie Company
$79
Merck Sharp & Dohme LLC
$78
GlaxoSmithKline, LLC.
$77
Kyowa Kirin, Inc.
$76
Mirati Therapeutics, Inc.
$59
AMAG Pharmaceuticals, Inc.
$50
Sirtex Medical Inc
$50
Regeneron Healthcare Solutions, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$47
Alnylam Pharmaceuticals Inc.
$42
Lexicon Pharmaceuticals, Inc.
$41
AbbVie Inc.
$41
Genentech USA, Inc.
$41
Blueprint Medicines Corporation
$39
Bayer HealthCare Pharmaceuticals Inc.
$39
JAZZ PHARMACEUTICALS INC.
$35
Kite Pharma, Inc.
$34
Karyopharm Therapeutics Inc.
$34
Coherus Biosciences Inc.
$32
Immunomedics, Inc.
$30
Rigel Pharmaceuticals, Inc.
$26
SOBI, INC
$25
Telix Pharmaceuticals
$22
Spectrum Pharmaceuticals Inc.
$20
G1 Therapeutics, Inc.
$19
Clovis Oncology, Inc.
$18
Jazz Pharmaceuticals Inc.
$18
Sobi, Inc
$18
Alexion Pharmaceuticals, Inc.
$17
Fortovia Therapeutics, Inc.
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$16
TerSera Therapeutics LLC
$16
INSYS Therapeutics Inc
$14
Heron Therapeutics, Inc.
$14
Aveo Pharmaceuticals, Inc.
$12
Gilead Sciences, Inc.
$12
Prometheus Laboratories Inc.
$11
Top 3 companies account for 21.7% of all-time payments
Associated products mentioned in payments ›
6 · ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Aranesp · BALVERSA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DIFICID · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · Folotyn · GIVLAARI · Halaven · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Nplate · ONUREG · OPDIVO · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · Proleukin · Prolia · REBLOZYL · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SYNDROS · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TEPMETKO · TIBSOVO · Tavalisse · Tazverik · Trodelvy · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · XARELTO · XERMELO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
289
Per 100K population
50.2
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schnall is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schnall experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Schnall performed 79,200 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schnall receive payments from pharmaceutical companies?
Yes. Dr. Schnall received a total of $8,643 from 68 companies across 467 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schnall's costs compare to other hematology & oncology specialists in Bryn Mawr?
Dr. Schnall's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schnall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Bryn Mawr
Browse hematology & oncology specialists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology